Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc. (VIRX) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 71 transactions totaling $496.4K, demonstrating a bearish sentiment with -$309.5K in net insider flow. The most recent transaction on Aug 25, 2024 involved a transaction of 9,034 shares valued at $0.
VIRX Insider Activity Summary
Who Is Buying VIRX Stock?
No significant insider buying has been recorded for VIRX in the recent period.
Who Is Selling VIRX Stock?
No significant insider selling has been recorded for VIRX in the recent period.
Is Viracta Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VIRX is bearish with an Insider Alignment Score of 19/100 and a net flow of -$309.5K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
VIRX Frequently Asked Questions
Understanding VIRX Insider Activity
Insider trading at Viracta Therapeutics, Inc. (VIRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading VIRX stock, having executed 71 transactions in the past 90 days. The most active insider is Ivor Royston (Executive), who has made 16 transactions totaling $170.1K.
Related Tools
Track Viracta Therapeutics, Inc. Insider Activity
Get notified when executives and directors at VIRX file new Form 4 transactions